Suppr超能文献

从婴儿男孩中分离无饲养层的精原干细胞的培养。

Xeno-Free Propagation of Spermatogonial Stem Cells from Infant Boys.

机构信息

Laboratory of Reproductive Biology, Rigshospitalet, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.

Department of Urology, Aksaray University School of Medicine, Aksaray 68100, Turkey.

出版信息

Int J Mol Sci. 2019 Oct 29;20(21):5390. doi: 10.3390/ijms20215390.

Abstract

Spermatogonial stem cell (SSC) transplantation therapy is a promising strategy to renew spermatogenesis for prepubertal boys whose fertility is compromised. However, propagation of SSCs is required due to a limited number of SSCs in cryopreserved testicular tissue. This propagation must be done under xeno-free conditions for clinical application. SSCs were propagated from infant testicular tissue (7 mg and 10 mg) from two boys under xeno-free conditions using human platelet lysate and nutrient source. We verified SSC-like cell clusters (SSCLCs) by quantitative real-time polymerase chain reaction (PCR) and immune-reaction assay using the SSC markers undifferentiated embryonic cell transcription factor 1 (UTF1), ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), GDNF receptor alpha-1 (GFRα-1) Fα and promyelocytic leukaemia zinc finger protein (PLZF). The functionality of the propagated SSCs was investigated by pre-labelling using green fluorescent Cell Linker PKH67 and xeno-transplantation of the SSCLCs into busulfan-treated, therefore sterile, immunodeficient mice. SSC-like cell clusters (SSCLCs) appeared after 2 weeks in primary passage. The SSCLCs were SSC-like as the UTF1, UCHL1, GFRα1 and PLZF were all positive. After 2.5 months' culture period, a total of 13 million cells from one sample were harvested for xenotransplantation. Labelled human propagated SSCs were identified and verified in mouse seminiferous tubules at 3-6 weeks, confirming that the transplanted cells contain SSCLCs. The present xeno-free clinical culture protocol allows propagation of SSCs from infant boys.

摘要

精原干细胞(SSC)移植疗法是一种有前途的策略,可以为生育能力受损的青春期前男孩更新精子发生。然而,由于冷冻保存的睾丸组织中 SSC 的数量有限,因此需要进行 SSC 的增殖。为了临床应用,这种增殖必须在无动物源条件下进行。我们使用人血小板裂解液和营养源,从两个男孩的婴儿睾丸组织(7 毫克和 10 毫克)中,在无动物源条件下增殖 SSC。我们通过使用 SSC 标记物未分化胚胎细胞转录因子 1(UTF1)、泛素羧基末端水解酶同工酶 L1(UCHL1)、GDNF 受体 alpha-1(GFRα-1)Fα和早幼粒细胞白血病锌指蛋白(PLZF)的定量实时聚合酶链反应(PCR)和免疫反应检测来验证 SSC 样细胞簇(SSCLC)。通过使用绿色荧光 Cell Linker PKH67 进行预标记,并将 SSCLCs 异种移植到接受白消安处理的无菌免疫缺陷小鼠中,来研究增殖的 SSC 的功能。在原代培养第 2 周后出现了 SSC 样细胞簇(SSCLC)。SSCLC 是 SSC 样的,因为 UTF1、UCHL1、GFRα1 和 PLZF 均为阳性。经过 2.5 个月的培养期,从一个样本中收获了总共 1300 万个细胞进行异种移植。在 3-6 周时,在小鼠曲细精管中鉴定和验证了标记的人源性增殖 SSC,证实移植细胞含有 SSCLC。本无动物源临床培养方案允许从婴儿男孩中增殖 SSC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cd0/6862004/f00c661f8bd4/ijms-20-05390-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验